Biostage Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14,008.00
5,272.00
7,456.00
2,941.00
4,038.00
1,355
Total Accounts Receivable
22.00
32.00
21.00
42.00
-
176
Inventories
38.00
207.00
75.00
-
-
-
Other Current Assets
421.00
317.00
330.00
503.00
375.00
623
Total Current Assets
14,489.00
5,828.00
7,882.00
3,486.00
4,413.00
2,154
Net Property, Plant & Equipment
575.00
1,376.00
1,074.00
1,065.00
632.00
479
Total Assets
15,064.00
7,204.00
8,956.00
4,551.00
5,045.00
2,633
Accounts Payable
244.00
-
357.00
962.00
923.00
Other Current Liabilities
251.00
710.00
297.00
1,815.00
699.00
Total Current Liabilities
495.00
710.00
654.00
2,777.00
1,622.00
Total Liabilities
495.00
710.00
654.00
2,777.00
1,622.00
Common Equity (Total)
14,569.00
6,494.00
8,302.00
1,774.00
1,948.00
Total Shareholders' Equity
14,569.00
6,494.00
8,302.00
1,774.00
3,423.00
Total Equity
14,569.00
6,494.00
8,302.00
1,774.00
3,423.00
Liabilities & Shareholders' Equity
15,064.00
7,204.00
8,956.00
4,551.00
5,045.00
Preferred Stock (Carrying Value)
-
-
-
-
1,475.00

About Biostage

View Profile
Address
84 October Hill Road
Holliston Massachusetts 01746
United States
Employees -
Website http://www.biostage.com
Updated 07/08/2019
Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.